Barrett Esophagus Clinical Trials in Ann Arbor, Michigan

4 studies are recruiting for barrett esophagus in Ann Arbor, Michigan right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus

    This phase II trial tests how well itraconazole works in combination with the usual standard of care endoscopy with ablation for the prevention of esophageal cancer in patients who have high-risk Barrett's esophagus (BE). BE is a condition in which the lining of the esophagus changes and becomes mo…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    University of Michigan Rogel Cancer Center, Ann Arbor, Michigan
    Locations
    6 in total
    Run by
    National Cancer Institute (NCI)

    See if you can join NCT06732388 on ClinicalTrials.gov

  2. Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia

    The purpose of this study is to learn the best approach to treating patients with known or suspected Barrett's esophagus by comparing endoscopic surveillance to endoscopic eradication therapy. To diagnose and manage Barrett's esophagus and low-grade dysplasia, doctors commonly use procedures called…

    Stage
    Not phased
    Ages
    18 to 89
    Site
    University of Michigan, Ann Arbor, Michigan
    Locations
    30 in total
    Run by
    University of Colorado, Denver

    See if you can join NCT05753748 on ClinicalTrials.gov

  3. Obeticholic Acid for Prevention in Barrett's Esophagus

    This phase II trial studies the effect of obeticholic acid in treating patients with Barrett's esophagus. Bile acids present in duodenogastroesophageal reflux contribute to neoplastic progression in Barrett's esophagus. Obeticholic acid has shown anti-cholestatic, anti-inflammatory and anti-fibroti…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    University of Michigan Rogel Cancer Center, Ann Arbor, Michigan
    Locations
    8 in total
    Run by
    National Cancer Institute (NCI)

    See if you can join NCT04939051 on ClinicalTrials.gov

  4. Longitudinal Oral Microbiome Sampling for BE

    This is a longitudinal cohort study to assess the impact of repeated sampling of an oral microbiome signature for Barrett's esophagus (BE). Potential participants will be identified through chart review of patients who have had an endoscopy in the past three years.

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Michigan, Ann Arbor, Michigan
    Locations
    2 in total
    Run by
    Columbia University

    See if you can join NCT05133102 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.